I am pleased to announce that Dr. Beatrice Golomb, University of California San Diego, has been able to successfully publish a paper with four case reports of individuals suffering from Fluoroquinolone Toxicity. The paper was officially accepted by BMJ, considered as one of the most influential general medicine journals in the world, on September 1, 2015. (See link below for access).
Dr. Golomb has been attempting, over the last several years, to get more case studies on Fluoroquinolone toxicity on the national academic medical radar. Her tenacious efforts are starting to pay off.
Although it only encompasses four case studies, it represents another major milestone in the forward movement for the acknowledgement of Fluoroquinolone Toxicity (FQ).
As I have mentioned before, myself, and three other floxies, form a team that have been reaching out to researchers, media and other professionals for over seven years. Dr. Golomb was one of three major academic researchers that saw the true impact of FQ toxicity and agreed to work with us on behalf of the FQ community. We have been loosely working with her for many years now.
I want to also thank our very own Alan Redd PhD who assisted with this paper and is listed as one of the co-authors. I am also honored that my individual case appears as one of the cases in the paper.
Dr. Golomb is still collecting data from those who have been affected by FQ toxicity through her UCSD Fluoroquinolone Effects Study located at http://fqstudy.info/Fluoroquinolone_Effects_Study/Welcome.html. The data that she is collecting is vitally important not only to FQ research but other research as well. She wholeheartedly believes that in the future we will see biological markers in the FQ community that will benefit those with gulf war syndrome and vice versa. Dr. Golomb fully acknowledges the severity of the adverse effects that FQ’s have on the lives of sufferers and will continue to push for more academic acknowledgement of FQ toxicity.
It is important to note that Dr. Golomb accepts no financial support for her research from pharmaceutical companies. Because of that, funding is limited for FQ research. So, if you know someone who wants to contribute to a worthy FQ research goal, donating to the “Fluoroquinolone Effects Study” care of UCSD is the way to go. To learn how to donate to Dr. Golomb’s work you can go here: http://fqstudy.info/Fluoroquinolone_Effects_Study/Contribute.html Instructions on how to contribute are listed. Donations should be tax deductible, but please check with your tax advisor for specific questions.
Our FQ team will be working closely with Dr. Golomb as she takes research to the next level in the near future. Stay tuned here as I will be sure to inform the FQ community of any pertinent developments with her, along with developments with other researchers that we work with.
You can access Dr. Golomb’s for viewing here: Fluoroquinolone-induced serious, persistent, multisymptom adverse effects *
Stayed tuned to My Quin story for timely updates on our interactions with the FDA, Dr. Bennett and the Citizen Petition, and community related research.
* Copyright 2015 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit